pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
teneobio PRESS RELEASE ARCHIVE
Oct 27, 2021
Newly-Formed Ancora Biotech Will Continue Operations of Teneobio Spin-offs After Successful Acquisition of Teneobio by Amgen
Oct 19, 2021
Amgen Successfully Completes Acquisition Of Teneobio, Inc.
Jul 27, 2021
Amgen To Acquire Privately Held Teneobio For $900 Million In Cash With Future Contingent Milestone Payments
Apr 5, 2021
Teneobio Announces Achievement of Milestone Payment as Janssen Advances Phase I Study of Bispecific JNJ-75348780 for the Treatment of NHL and CLL
Apr 2, 2020
Kite Licenses Antibodies and Establishes Collaboration With Teneobio in Multiple Myeloma
Oct 17, 2019
Teneobio and Selexis Expand Relationship with Three Commercial License Agreements for Multi-specific Antibody Candidates in Oncology
Feb 11, 2019
AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma
Dec 17, 2018
Teneobio and Selexis Enter Second Services Agreement to Develop Research Cell Banks as Teneobio Prepares to Advance Three Additional Oncology-Targeting Multi-Specific UniAbs into the Clinic
Jun 12, 2017
Selexis SA and TeneoBio, Inc. Team Up to Advance the Development of UniAbs Targeting Cancer
Sep 16, 2016
Ligand Enters OmniAb License Agreement with TeneoBio, Inc.
